KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Teladoc Health (TDOC) Revenue (2016 - 2026)

Teladoc Health's Revenue history spans 13 years, with the latest figure at $613.8 million for Q1 2026.

  • On a quarterly basis, Revenue fell 2.47% to $613.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $2.5 billion, a 1.5% decrease, with the full-year FY2025 number at $2.5 billion, down 1.54% from a year prior.
  • Revenue hit $613.8 million in Q1 2026 for Teladoc Health, down from $642.3 million in the prior quarter.
  • Over the last five years, Revenue for TDOC hit a ceiling of $660.5 million in Q4 2023 and a floor of $565.4 million in Q1 2022.
  • Historically, Revenue has averaged $630.7 million across 5 years, with a median of $637.7 million in 2022.
  • Biggest five-year swings in Revenue: grew 24.62% in 2022 and later dropped 3.03% in 2024.
  • Tracing TDOC's Revenue over 5 years: stood at $637.7 million in 2022, then rose by 3.58% to $660.5 million in 2023, then dropped by 3.03% to $640.5 million in 2024, then rose by 0.28% to $642.3 million in 2025, then fell by 4.43% to $613.8 million in 2026.
  • Business Quant data shows Revenue for TDOC at $613.8 million in Q1 2026, $642.3 million in Q4 2025, and $626.4 million in Q3 2025.